Insider filing · RXO

Thomas A Szlosek bought $251K of RXO (RXO)

Executed Nov 7 2025, disclosed Nov 12 2025, 5 days later.

Over the 21 trading sessions from the disclosed entry session (Nov 12 2025), the stock returned +24.6% (delay-adjusted); from the execution session (Nov 7 2025), +7.3%. Derived: entry at the session's open, exit at the close 20 sessions later.

TS Thomas A Szlosek Director profile →

Thomas A Szlosek (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in RXO. Across 1 priced purchase filing, the average 21-session return was +7.3% from execution and +24.6% from disclosure (delay-adjusted; derived). The largest single filing was $251K of RXO (20,308 sh × $12.37, as filed), executed Nov 7 2025.

RXO RXO RXO · 8 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→